<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01470976</url>
  </required_header>
  <id_info>
    <org_study_id>0565/11</org_study_id>
    <nct_id>NCT01470976</nct_id>
  </id_info>
  <brief_title>Goal-directed Resuscitation in High-risk Patients Undergoing Cardiac Surgery</brief_title>
  <acronym>GRICS</acronym>
  <official_title>Randomized Controlled Trial of Goal-directed Resuscitation in High-risk Patients Undergoing Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of the study is to investigate whether a goal-directed resuscitation therapy
      in high-risk patients through cardiac index optimization using the LiDCO Rapid device reduces
      complications after cardiac surgery. The hypothesis is that there are better outcomes when
      achieving a cardiac index higher than 3L/min/m2 in those patients with an arterial lactate
      higher than 1.5 mmol/L.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of death or major postoperative complications</measure>
    <time_frame>within 30 days after cardiac surgery</time_frame>
    <description>Death or one of the following complications: stroke, renal failure, respiratory complications, cardiovascular complications, deep wound infection and reoperation for any reason.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU stay and hospital stay.</measure>
    <time_frame>within 30 days after cardiac surgery</time_frame>
    <description>To compare the number of days of ICU stay and hospital stay between groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue hypoperfusion markers</measure>
    <time_frame>within 30 days after cardiac surgery</time_frame>
    <description>To compare levels of DO2, lactate, ScvO2, base excess and venous to arterial carbon dioxide difference between groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular measures</measure>
    <time_frame>within 30 days after cardiac surgery</time_frame>
    <description>To compare levels of BNP, myocardial enzymes, echocardiographic measures and free-days of vasopressors and inotropes between groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation</measure>
    <time_frame>within 30 days after cardiac surgery</time_frame>
    <description>To compare the number of mechanical ventilation free-days between groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluid balance</measure>
    <time_frame>during ICU stay</time_frame>
    <description>To compare fluid balance during ICU stay between groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Perioperative Hemodynamic Optimization</condition>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Goal-directed Therapy (GDT) Protocol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Protocol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Goal-directed Resuscitation Therapy (GDT)</intervention_name>
    <description>A target value of a cardiac index (CI) greater than 3.0 L/min/m2 will be sought.
The first step will be fluid resuscitation with 250ml aliquots of Lactated Ringer's solution whenever the CI is lower than 3,0 L/min/m2 and systolic volume index (SVI) is lower than 35ml/m2. The fluid challenge will be stopped if the CVP rises by more than 4 mmHg during the infusion period.
When the CI is lower than or equal to 3,0L/min/m2 and SVI higher than or equal to 35 ml/m2, dobutamine will be initiated with increasing doses up to 20mcg/kg/min.
The final step will be red blood transfusion to reach a hematocrit higher than 28%.</description>
    <arm_group_label>Goal-directed Therapy (GDT) Protocol</arm_group_label>
    <other_name>LiDCO Rapid will be used to calculate CI and SVI.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard protocol</intervention_name>
    <description>The control group will be managed by the anesthetic team in the operative room and by the surgical ICU staff in the postoperative period according to institutional protocol of hemodynamic monitoring.</description>
    <arm_group_label>Standard Protocol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All elective primary and redo adult cardiac surgical patients for coronary artery
             bypass grafting, valve procedure or combined procedures

          -  Adults patients

          -  Written informed consent

          -  One of the following criteria:

               -  EuroSCORE (European System for Cardiac Operative Risk Evaluation) higher than or
                  equal to 6

               -  Ejection fraction lower than 50%

               -  Recent myocardial infarction

               -  Unstable angina

        Exclusion Criteria:

          -  Age less than 18 years

          -  Infectious endocarditis

          -  Transplant procedures

          -  Emergency procedures

          -  Pulmonary hypertension

          -  Preoperative cardiogenic shock or use of dobutamine

          -  Congenital procedures

          -  Need for intra-aortic balloon pump (IABP)

          -  Noradrenaline dose higher than 1mcg/kg/min

          -  Pregnancy

          -  Patients who refused participation in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ludhmila A Hajjar, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto do Coracao - InCor / HCFMUSP</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Hajjar LA, Fukushima JT, Osawa E, Almeida JP, Galas FR. Dobutamine administration in patients after cardiac surgery: beneficial or harmful? Crit Care. 2011;15(5):444. doi: 10.1186/cc10439. Epub 2011 Sep 27.</citation>
    <PMID>21958463</PMID>
  </reference>
  <reference>
    <citation>Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Leão WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NA, Auler JO Jr. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010 Oct 13;304(14):1559-67. doi: 10.1001/jama.2010.1446.</citation>
    <PMID>20940381</PMID>
  </reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2011</study_first_submitted>
  <study_first_submitted_qc>November 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2011</study_first_posted>
  <last_update_submitted>February 3, 2016</last_update_submitted>
  <last_update_submitted_qc>February 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Ludhmila Abrahão Hajjar</investigator_full_name>
    <investigator_title>Supervisor of the Surgical Intensive Care Unit of the Heart Institute</investigator_title>
  </responsible_party>
  <keyword>Goal-directed therapy</keyword>
  <keyword>Hemodynamic optimization</keyword>
  <keyword>Cardiac surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

